FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693960019 | Cromolyn sodium 20 mg/mL and xylometazoline hydrochloride 250 microgram/mL nasal spray | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3693961015 | Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3782389016 | Sodium cromoglicate 20 mg/mL and xylometazoline hydrochloride 250 microgram/mL nasal spray | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 468271016 | Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 468271016 | Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 468272011 | Sodium cromoglycate compound 2% nasal spray | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 468272011 | Sodium cromoglycate compound 2% nasal spray | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 721083011 | Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray (substance) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1192367012 | Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1192367012 | Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693959012 | Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693960019 | Cromolyn sodium 20 mg/mL and xylometazoline hydrochloride 250 microgram/mL nasal spray | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3693961015 | Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3782389016 | Sodium cromoglicate 20 mg/mL and xylometazoline hydrochloride 250 microgram/mL nasal spray | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Is a | Product containing sodium cromoglycate in topical dosage form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Substance with mast cell stabilizer mechanism of action (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Sodium cromoglicate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Is a | Sodium cromoglycate+xylometazoline hydrochloride | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Xylometazoline hydrochloride (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Bronchodilator | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Analgesic (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Anti-inflammatory agent | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has manufactured dose form | Nasal dose form (dose form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Is a | Cromoglicic acid-containing product in nasal dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Is a | Product containing xylometazoline in nasal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has manufactured dose form | Nasal spray | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has precise active ingredient | Xylometazoline hydrochloride (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has concentration strength numerator unit | mg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has concentration strength denominator unit (attribute) | Milliliter (qualifier value) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has concentration strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has concentration strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has basis of strength substance (attribute) | Xylometazoline hydrochloride (substance) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has concentration strength denominator unit (attribute) | Milliliter (qualifier value) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has basis of strength substance (attribute) | Sodium cromoglicate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has precise active ingredient | Sodium cromoglicate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Is a | Cromoglicic acid and xylometazoline only product in nasal dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has precise active ingredient | Xylometazoline hydrochloride (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has precise active ingredient | Sodium cromoglicate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has basis of strength substance (attribute) | Xylometazoline hydrochloride (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | Has basis of strength substance (attribute) | Sodium cromoglicate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets